A randomized, multicentric, comparative evaluation of aceclofenac–paracetamol combination with aceclofenac alone in Indian patients with osteoarthritis flare-up

Bibliography

• Boureau F, Schneid H, Zeghari N, et al. The IPSO study: ibuprofen, paracetamol study in osteoarthritis. A randomized comparative clinical study comparing the efficacy and safety of ibuprofen and paracetamol analgesic treatment of osteoarthritis of knee or hip. Ann Rheum Dis 2004;63:1028-34
   PubMed Web of Science ®Google Scholar
• Goswami R, Mishra SK, Kochupillai N. Prevalence & potential significance of vitamin D deficiency in Asian Indians. Indian J Med Res 2008;127:229-38
   PubMed Web of Science ®Google Scholar
• Sharma MK, Swami HM, Bhatia V, et al. An epidemiological study of correlates of osteo-arthritis in geriatric population of UT Chandigarh. Indian J Community Med 2007;32:1-3
   Google Scholar
• Parek A, Chandanwale AS, Oak J, et al. Efficacy and safety of aceclofenacin the treatment of osteoarthritis: a randomized double blind comparative clinical trial versus diclofenac-an indian experience. Curr Med Res Opin 2006;22(5):977-88
   PubMedGoogle Scholar
• Hadler NM. Knee pain in the malady – not osteoarthritis [editorial]. Ann Intern Med 1992;116:598-9
   PubMed Web of Science ®Google Scholar
• Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-Term Arthritis Safety Study. JAMA 2000;284:1247-55
   PubMed Web of Science ®Google Scholar
• Greenberg NJ. Update in gastroenterology. Ann Intern Med 1997;127:827-34
   PubMedGoogle Scholar
• Kehlet H, Dahl JB. The value of ‘multimodal’ or ‘balanced analgesia’ in postoperative pain treatment. Anaesth Analg 1993;77:1048-56
   PubMed Web of Science ®Google Scholar
• Brandt KD, Bradley JD. Should the initial drug used to treat osteoarthritis pain be a nonsteroidal anti-inflammatory drug? [editorial]. J Rheumatol 2001;28:467-73
   PubMedGoogle Scholar
• Jordan KM, Arden NK, Doherty M, et al. EULAR recommendations 2003: an evidence-based approach to the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62:1145-55
   PubMed Web of Science ®Google Scholar
• Eccles M, Freemantle N, Mason J. North of England evidence based guideline for non-steroidal anti-inflammatory drugs versus basic analgesic in treating the pain of degenerative arthritis. The North of England Non-Steroidal Anti-inflammatory Drug Guideline Development Group BMJ 1998;317:526-30
   PubMedGoogle Scholar
• American college of rheumatology subcommittee on osteoarthritis guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000;43:1905-15
   PubMed Web of Science ®Google Scholar
• Legrand E. Aceclofenac in the management of inflammatory pain. Expert Opin Pharmacother 2004;5:1347-57
   PubMed Web of Science ®Google Scholar
• Dooley M, Spencer CM, Dunn CJ. Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease. Drugs 2001;61:1351-78
   PubMed Web of Science ®Google Scholar
• Perez Busquier M, Calero E, Rodriguez M, et al. Comparison of aceclofenac with piroxicam in the treatment of osteoarthritis. Clin Rheumatol 1997;16:154-9
   PubMed Web of Science ®Google Scholar
• Giorgianni G, Ottaviani C, Soliano A, et al. Efficacy and tolerability of aceclofenac versus ketoprofen in the treatment of rheumatoid arthritis. Curr Ther Res 1992;51:1-10
   Google Scholar
• Batle-Gualda E, Figueroa M, Ivorra J, et al. The efficacy and tolerability of aceclofenac in the treatment of patients with ankylosing spondylitis: a multicentre controlled clinical trial. J Rheumatol 1996;23:1200-6
   PubMedGoogle Scholar
• Miceli-Richard C, le Bars M. Paracetamol in osteoarthritis of the knee. Ann Rheum Dis 2004;63:923-30
   PubMed Web of Science ®Google Scholar
• Acetomaminophen (Systemic). Drug information for the health care professional. Twenty first edition. USPDI, Micromedex Thomson Healthcare. 2001:1:p. 8-9
   Google Scholar
• Laurence DR, Bennett PN, Brown MJ. Individual NSAIDs. Eighth edition.In: Clinical pharmacology. Churchill Livingstone: London; 1997. p. 253, 260
   Google Scholar
• Martindale – the complete drug reference Ed. Sean C Sweetman. Pharmaceutical Press:London; Thirty third edition. 2003. p. 73
   Google Scholar
• Allerdyer C, Baarr L, Blake J, et al. Medicines compendium. Datapharm communication: London; 2002. p. 1594
   Google Scholar
• Brogden RN, Wiseman LR. Aceclofenac. A review of its pharmacodynamic properties and therapeutic potential in the treatment of rheumatic disorders and in pain management. Drugs 1996;52:113-24
   PubMed Web of Science ®Google Scholar
• Lequesne MG. The algofunctional indices for hip and knee osteoarthritis. J Rheumatol 1997;24:779-81
   PubMed Web of Science ®Google Scholar
• American college of rheumatology subcommittee on osteoarthritis guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 Update. Arthritis Rheum 2000;43:1905-15
   PubMed Web of Science ®Google Scholar
• Coluzzi PH. Cancer pain management: newer perspectives on opioids and episodic pain. Am J Hosp Palliat Care 1998;15:13-22
   PubMedGoogle Scholar
• Simmonds MA. Management of breakthrough pain due to cancer. Oncology 1999;13:1103-8
   PubMed Web of Science ®Google Scholar
• Portenoy RK, Payne D, Jacobsen P. Break through pain: characteristics and impact in patients with cancer pain. Pain 1999;81:129-34
   PubMed Web of Science ®Google Scholar
• Scott-Lennox JA, McLaughlin-Miley C, Lennox RD, et al. Stratification of flare intensity identifies placebo responders in a treatment efficacy trial of patients with osteoarthritis arthritis & rheumatism. Am Coll Rheumatol 2001;44:1599-607
   Google Scholar
• McConnell S, Kolopack P, Davis AM. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. Arthritis Rheum 2001;45:453-61
   PubMed Web of Science ®Google Scholar
• Ehrich EW, Davies GM, Warson DJ, et al. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities Osteoarthritis Index questionnaire and global assessments in patients with osteoarthritis. J Rheumatol 2000;27:2635-41
   PubMed Web of Science ®Google Scholar
• Batlle-Gualda E, Roman Ivorra J, Carbonell J, et al. Aceclofenac vs paracetamol in the management of symptomatic osteoarthritis of the knee: a double-blind 6-week randomized controlled trial. Osteoarthritis Cartilage 2007;15:900-8
   PubMed Web of Science ®Google Scholar